Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1315

Short-chain chondroitin sulfate oligosaccharides produced from enzymatic hydrolysis of chondroitin sulfate

Intended Use: Intended for use as an ingredient in selected nutritional beverages and powders, sport and energy drinks, and soft candies at levels up to 400 mg/serving (excluding use in infant formula and products under the jurisdiction of the United States Department of Agriculture).
Basis: Scientific procedures
Notifier: Nanjing Letop Biotechnology Co., Ltd.
Notifier Address: No. 5 Xinghe Road
Nanjing Economic and Technolgocial Development Zone
Jiangsu, 210038
CHINA
GRAS Notice (releasable information): GRN 1315 (in PDF) (6 MB)
FDA's Letter: Pending
-
-